Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries

Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries

Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is treatable but guideline‐directed medical therapy (GDMT) may not be affordable or accessible to people living with the disease. Methods and results In this cross‐sectional survey, we investigated the price, affordability, and acces...

Full description

Bibliographic Details
Main Authors: Tauben Averbuch, Meisam Esfahani, Rani Khatib, James Kayima, Juan Jaime Miranda, Rishi K. Wadhera, Faiez Zannad, Ambarish Pandey, Harriette G. C. Van Spall
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:ESC Heart Failure
Subjects:
Accessibility
Affordability
Cost
Equity
Heart failure
Pharmaco‐disparities
Online Access:https://doi.org/10.1002/ehf2.14468

Internet

https://doi.org/10.1002/ehf2.14468

Similar Items